Project Cure CRC
Request for Proposals
Project Cure CRC has announced a rolling Request for Proposals (RFP), making available tens of millions of dollars to academic and industry researchers whose work aims to expedite colorectal cancer research to a curable science. Download the RFP for details and submit your proposal at ProposalCentral.
Hope for today's patients
With bold and urgent action, Project Cure CRC seeks to cultivate breakthroughs in colorectal cancer diagnosis, treatment, metastasis, and survivorship. The project will ignite innovative treatments to end colorectal cancer now.
Cure CRC Summit
In December 2024, the Cure CRC Summit welcomed more than 100 prominent scientists to foster partnerships that will challenge the status quo of colorectal therapies and discover new trajectories toward a cure.
Support the project
The Colorectal Cancer Alliance invites the public, corporations, foundations, and philanthropic individuals to join us by contributing to Project Cure CRC.
Project Cure CRC Co-Chairs
Michael Sapienza
CEO, Colorectal Cancer Alliance
Katie Chudnovsky
Board Member, Colorectal Cancer AllianceScientific Co-Chairs
John Marshall, MD
Georgetown UniversityScott Kopetz, MD, PhD, FACP
MD Anderson Cancer CenterChristopher Lieu, MD
University of Colorado Cancer CenterPatient Advocate Co-Chair
John Woerner
mCRC Survivor and Board Member, Colorectal Cancer AllianceAlliance Project Lead
David Fenstermacher, PhD
Senior Director of Research and Medical Affairs, Colorectal Cancer AllianceGrant Review Committee
Scott Kopetz, MD, PhD, FACP
MD Anderson Cancer CenterChristopher Lieu, MD
University of Colorado Cancer CenterJohn Marshall, MD
Georgetown University
Top resources
Where breakthroughs begin: Project Cure CRC spotlight on Dr. Lisa Mielke
hrough Project Cure CRC, the Alliance is fueling bold, early-stage research with the potential to transform colorectal cancer treatment. Dr. Lisa Mielke’s groundbreaking work explores how the gut’s immune system and nerve signaling influence cancer growth—opening the door to new therapeutic approaches, including repurposed existing drugs. This is what’s possible when promising ideas get the support they need to move forward.
Bringing biomarker testing within reach: CLEAR for CRC to empower patients from day one
Biomarker testing can guide colorectal cancer treatment and improve outcomes. Learn how CLEAR for CRC is helping patients access this critical tool.
Project Cure CRC researcher seeks next big breakthrough
Meet Project Cure CRC researcher Kevin Van der Jeught, whose mRNA-based immunotherapy research aims to unlock new treatments for colorectal cancer patients.